Elacytarabine

艾西拉滨

Report date: 2022/12/07 17:52:42
NME

Base Information

Drug NameElacytarabine
Drug Alias NameelacytarabinumelacitarabinaELACYTUNII-TA7WJG93ARCP-4055 +[6] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsNeoplasm MetastasisHematologic NeoplasmsOvarian Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[14] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesClavis Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClavis Pharma
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisHematologic NeoplasmsOvarian Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksKEGG